Clinical Trial Update: 1,5-AG as a Marker of Postprandial Hyperglycemia and Glucose Variability in Well-controlled Type 2 Diabetes Mellitus

View source ↗

Summary

This clinical trial evaluated 1,5-anhydroglucitol (1,5-AG) as a biomarker of postprandial hyperglycemia and glucose variability in well-controlled Type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED